Release Date: September 30, 2024
Expiration Date: September 30, 2025
Activity Overview
Along the treatment continuum for patients with DLBCL, numerous decisions regarding treatment need to be made to ensure optimal outcomes. This also necessitates knowledge of the adverse events associated with each approach. In this educational activity, experts in the management of DLBCL discuss treatment options and their associated safety profiles, with practical advice on the best approaches for different toxicities that may jeopardize the success of therapy.
Target Audience
This online educational activity is primarily directed toward academic and community hematologists, oncologists, oncology nurses, oncology advanced practice providers, oncology pharmacists, and other health care providers involved in the diagnosis and management of patients with DLBCL.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Recognize adverse events associated with the different classes of targeted therapies used in R/R DLBCL
- Formulate strategies for the monitoring, identification, and mitigation of toxicities linked to targeted agents in patients with DLBCL
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
